Bad Drugs or Big Law Stress? Jury to Decide in Reed Smith Partner's Suicide
Stewart Dolin, a leader of Reed Smith’s corporate department, committed suicide in 2010. His widow seeks $12 million for his death, alleging it was the result of an antidepressant whose suicidal side effects were covered up by GlaxoSmithKline. The pharmaceutical giant claims that Dolin’s death was the result of an unpleasant work environment.